PHARMA-BIO SERV, INC. Deferred Foreign Income Tax Expense (Benefit)
PHARMA-BIO SERV, INC. (PBSV) reported Deferred Foreign Income Tax Expense (Benefit) of $62.70 thousand for the 12-month period ending 2021-10-31, per its 10-K filed 2022-02-11.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2022-02-11
- PHARMA-BIO SERV, INC. deferred foreign income tax expense (benefit) for fiscal 2021 was $62.70K, a 40.29% decline from fiscal 2020.
- PHARMA-BIO SERV, INC. deferred foreign income tax expense (benefit) for fiscal 2020 was $105.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2021-10-31 | $62.70K 10-K · filed 2022-02-11 |
| 2020-10-31 | $105.00K 10-K · filed 2022-02-11 |